Luis Miguel
Antón Aparicio
Complexo Hospitalario Universitario de Ourense
Orense, EspañaPublicacións en colaboración con investigadores/as de Complexo Hospitalario Universitario de Ourense (3)
2013
-
Comprehensive overview of the efficacy and safety of sorafenib in advanced or metastatic renal cell carcinoma after a first tyrosine kinase inhibitor
Clinical and Translational Oncology, Vol. 15, Núm. 6, pp. 425-433
-
Erratum: Comprehensive overview of the efficacy and safety of sorafenib in advanced or metastatic renal cell carcinoma after a first tyrosine kinase inhibitor (Clinical and Translational Oncology DOI: 10.1007/s12094-012-0985-x)
Clinical and Translational Oncology
2012
-
Sunitinib: The first to arrive at first-line metastatic renal cell carcinoma
Advances in Therapy, Vol. 29, Núm. 3, pp. 202-217